Attached Carole Ho - 06 Dec 2021 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
06 Dec 2021
Net transactions value
-$62,760
Form type
4
Filing time
08 Dec 2021, 16:35:26 UTC
Previous filing
25 Aug 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale $62,760 -1,476 -1.9% $42.52 76,316 06 Dec 2021 Direct F1, F2
holding DNLI Common Stock 25,000 06 Dec 2021 See footnote F3
holding DNLI Common Stock 158,630 06 Dec 2021 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 75,906 restricted stock units.
F3 The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
F4 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.